Surat Pharmaceuticals Private Limited
About Surat Pharmaceuticals Private Limited
Data last updated:
Surat Pharmaceuticals Private Limited is a private limited company based in Bhilai, Chhattisgarh, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 03 December 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Chhattisgarh, under CIN U51909CT2018PTC008933. Its GSTIN is 22ABBCS2177D1ZR (Chhattisgarh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pushpa Tiwari and Tushar Tiwari.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Block No. – 49 Plot No. – 12 Gurudwara Road Nehru Nagar (West), Bhilai, Chhattisgarh, India – 490001.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.44 Lakh, a growth of 95% compared to the previous year. For the same year it recorded a net loss of ₹2.05 Lakh (net margin -27.6%) and EBITDA of -₹1.97 Lakh (EBITDA margin -26.5%).
Company details
Contact details
Surat Pharmaceuticals Private Limited's registered office is in Bhilai, Chhattisgarh. Its e-mail address is in the company report.
- Email
- Registered AddressBlock No. – 49 Plot No. – 12 Gurudwara Road Nehru Nagar (West), Bhilai, Chhattisgarh, India – 490001
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Surat Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Surat Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Surat Pharmaceuticals Private Limited, buy the company report.
Financials of Surat Pharmaceuticals Private Limited
FY 2025 filings availableSurat Pharmaceuticals Private Limited reported revenue of ₹7.44 Lakh (up 95% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 95% in the latest year. EBITDA fell 82% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.97 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.05 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -26.5% | ||||
| Net Profit Margin | -27.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Surat Pharmaceuticals Private Limited, buy the company report.
Board of directors of Surat Pharmaceuticals Private Limited
Surat Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pushpa Tiwari | Director | 03 Dec 2018 | 7 Years 10 Months | Current |
| Tushar Tiwari | Director | 03 Dec 2018 | 7 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Surat Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Surat Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Surat Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 22ABBCS2177D1ZR | Chhattisgarh | Active | 29 Apr 2019 |
To see the full GST registrations and return filing status of Surat Pharmaceuticals Private Limited, buy the company report.
Recent activity
Surat Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Pushpa Tiwari was appointed as Director on 03 Dec 2018.
Frequently asked questions
Surat Pharmaceuticals is an active private limited company based in Bhilai, Chhattisgarh, India. The company works in specialty, within the trading industry. It was incorporated on 03 December 2018 (8+ years old) and is registered under CIN U51909CT2018PTC008933.
Surat Pharmaceuticals has 2 current directors:
- Pushpa Tiwari - Director
- Tushar Tiwari - Director
The latest financial statements of Surat Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Surat Pharmaceuticals is 22ABBCS2177D1ZR, registered in Chhattisgarh.
The CIN (Corporate Identification Number) of Surat Pharmaceuticals is U51909CT2018PTC008933. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Surat Pharmaceuticals was incorporated on 03 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Chhattisgarh.
Pushpa Tiwari was appointed as Director on 03 Dec 2018. Tushar Tiwari was appointed as Director on 03 Dec 2018.
The registered office of Surat Pharmaceuticals is at Block No. – 49 Plot No. – 12 Gurudwara Road Nehru Nagar West, Bhilai, Chhattisgarh, India – 490001.
Surat Pharmaceuticals operates in the trading industry, in the specialty segment.
Surat Pharmaceuticals can be reached at its registered office: Block No. – 49 Plot No. – 12 Gurudwara Road Nehru Nagar West, Bhilai, Chhattisgarh, India – 490001.